SpaceX Finalizes $60 Billion Acquisition of Cursor Following Successful IPO

تم التعديل بواسطة: Tatyana Hurynovich

SpaceX is set to complete its $60 billion acquisition of the startup Cursor. San Francisco-based Anysphere, the creator of the popular AI-powered coding tool, will become a wholly owned subsidiary of SpaceX.

The deal is expected to close in the third quarter, according to a regulatory filing released on Tuesday. This comes just one week after SpaceX's Wall Street debut.

Back in April, SpaceX secured the option to either acquire Cursor for $60 billion or pay $10 billion for a collaborative partnership. The company has now opted for a full buyout.

Launched in 2022, Cursor helped spearhead the "vibe coding" trend, where AI assistants handle the bulk of the programming work. The tool is a favorite among experienced developers, a user base that specifically appealed to SpaceX.

A partnership with xAI will grant access to the massive Colossus data center in Memphis for future product development. While Cursor competes with solutions from Anthropic and OpenAI, it also leverages their underlying technologies.

Following its IPO, SpaceX shares surged 19% on the first day of trading and have continued to climb. The acquisition of Cursor provides the company with access to a new audience and bolsters its AI standing amid intense rivalry with Anthropic and OpenAI.

What does this mean for the developers who have already integrated Cursor into their workflow?

This transaction highlights how rapidly SpaceX is expanding its footprint beyond aerospace, leveraging its recent stock market success.

16 مشاهدات

المصادر

  • SpaceX buys AI coding startup Cursor for $60 billion

التعليقات

اقرأ المزيد من المقالات حول هذا الموضوع:

OpenAI showed that AI agents can handle the slowest step in modern biology, making sense of huge experiments. By splitting a huge brain experiment among 1,946 AI agents, OpenAI got in 32 minutes what it estimates would take people months: a ranked list of leads for new

Image
OpenAI
OpenAI
@OpenAI

GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration? DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in

Reply
هل وجدت خطأً أو عدم دقة؟سننظر في ملاحظاتك في أقرب وقت ممكن.